1. Home
  2. DERM vs CRDL Comparison

DERM vs CRDL Comparison

Compare DERM & CRDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DERM
  • CRDL
  • Stock Information
  • Founded
  • DERM 2014
  • CRDL 2017
  • Country
  • DERM United States
  • CRDL Canada
  • Employees
  • DERM N/A
  • CRDL N/A
  • Industry
  • DERM Biotechnology: Pharmaceutical Preparations
  • CRDL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • DERM Health Care
  • CRDL Health Care
  • Exchange
  • DERM Nasdaq
  • CRDL Nasdaq
  • Market Cap
  • DERM 95.0M
  • CRDL 102.0M
  • IPO Year
  • DERM 2021
  • CRDL N/A
  • Fundamental
  • Price
  • DERM $5.19
  • CRDL $1.20
  • Analyst Decision
  • DERM Strong Buy
  • CRDL Strong Buy
  • Analyst Count
  • DERM 3
  • CRDL 3
  • Target Price
  • DERM $9.50
  • CRDL $9.00
  • AVG Volume (30 Days)
  • DERM 55.0K
  • CRDL 274.8K
  • Earning Date
  • DERM 03-20-2025
  • CRDL 03-31-2025
  • Dividend Yield
  • DERM N/A
  • CRDL N/A
  • EPS Growth
  • DERM N/A
  • CRDL N/A
  • EPS
  • DERM N/A
  • CRDL N/A
  • Revenue
  • DERM $57,771,000.00
  • CRDL N/A
  • Revenue This Year
  • DERM N/A
  • CRDL N/A
  • Revenue Next Year
  • DERM $36.49
  • CRDL N/A
  • P/E Ratio
  • DERM N/A
  • CRDL N/A
  • Revenue Growth
  • DERM N/A
  • CRDL N/A
  • 52 Week Low
  • DERM $2.85
  • CRDL $1.15
  • 52 Week High
  • DERM $6.89
  • CRDL $3.12
  • Technical
  • Relative Strength Index (RSI)
  • DERM 60.26
  • CRDL 41.60
  • Support Level
  • DERM $4.85
  • CRDL $1.15
  • Resistance Level
  • DERM $5.37
  • CRDL $1.51
  • Average True Range (ATR)
  • DERM 0.40
  • CRDL 0.10
  • MACD
  • DERM 0.02
  • CRDL -0.01
  • Stochastic Oscillator
  • DERM 70.49
  • CRDL 13.65

About DERM Journey Medical Corporation

Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.

About CRDL Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's lead product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.

Share on Social Networks: